| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8738672 | International Journal of Antimicrobial Agents | 2018 | 18 Pages |
Abstract
The collective findings demonstrate a clear dose-response relationship between vancomycin dose and AKI. As these analyses focused exclusively on dose-response relationships, additional preclinical data are needed to more clearly define vancomycin exposures that predict the onset of AKI.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
J. Nicholas O'Donnell, Nathaniel J. Rhodes, Cristina M. Miglis, Lejla Catovic, Jiajun Liu, Cameron Cluff, Gwendolyn Pais, Sean Avedissian, Medha D. Joshi, Brooke Griffin, Walter Prozialeck, Anil Gulati, Thomas P. Lodise, Marc H. Scheetz,